CFTR in K562 human leukemic cells

被引:9
|
作者
Assef, YA
Damiano, AE
Zotta, E
Ibarra, C
Kotsias, BA
机构
[1] Univ Buenos Aires, Inst Invest Med Alfredo Lanari, Fac Med, RA-1427 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Dept Fisiol, Fac Med, RA-1427 Buenos Aires, DF, Argentina
来源
关键词
CFTR; K562; cells; leukemia cells; ion channels; glibenclamide; DIDS; PCR; immunohistochemistry;
D O I
10.1152/ajpcell.00320.2002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In this study, the expression and functional characterization of CFTR ( cystic fibrosis transmembrane regulator) was determined in K562 chronic human leukemia cells. Expression of the CFTR gene product was determined by RT-PCR and confirmed by immunohistochemistry and Western blot analysis. Functional characterization of CFTR Cl- channel activity was conducted with patch-clamp techniques. Forskolin, an adenylyl cyclase activator, induced an anion-selective channel with a linear current-voltage relationship and a single-channel conductance of 11 pS. This cAMP-activated channel had a P-gluconate/P-Cl or P-F/P-Cl perm-selectivity ratio of 0.35 and 0.30, respectively, and was inhibited by the CFTR blocker glibenclamide and the anti-CFTR antibody MAb 13-1, when added to the cytoplasmatic side of the patch. Glibenclamide decreased the open probability increasing the frequency of open-to-closed transitions. Addition of 200 muM DIDS caused an irreversible block of the channels when added to the cytosolic side of inside-out patches. These and other observations indicate a widespread distribution of CFTR gene expression and suggest that this channel protein may function in most human cells to help maintain cellular homeostasis.
引用
收藏
页码:C480 / C488
页数:9
相关论文
共 50 条
  • [31] Berberine overcome the drug resistance of leukemic cells K562/A02.
    Cui, SX
    Qu, XJ
    Xie, YY
    Hou, JL
    Zhou, L
    Zhang, Q
    Xu, XM
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 : 3835S - 3835S
  • [32] Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells
    Richard Mould
    Marc D Pondel
    [J]. Cancer Cell International, 3
  • [33] CHARACTERISATION OF FERROXIDASES IN HUMAN LEUKAEMIC K562 CELLS
    White, Kenneth
    Goff, Phillip
    Evans, Robert
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (05) : E201 - E201
  • [34] Anti-cancer effects of deguelin on human leukemia K562 and K562/ADM cells In Vitro
    Qiuling Wu
    Yan Chen
    Hongli Liu
    Jing He
    [J]. Journal of Huazhong University of Science and Technology, 2007, 27 : 149 - 152
  • [35] Anti-cancer Effects of Deguelin on Human Leukemia K562 and K562/ADM Cells In Vitro
    吴秋玲
    陈燕
    刘红利
    何静
    [J]. Current Medical Science, 2007, (02) : 149 - 152
  • [36] Anti-cancer effects of deguelin on human leukemia K562 and K562/ADM cells in vitro
    Wu Qiuling
    Chen Yan
    Liu Hongli
    He Jing
    [J]. JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2007, 27 (02) : 149 - 152
  • [37] Stereoselective Accumulation of Propranolol Enantiomers in K562 and K562/ADR Cells
    Zheng, Xiao-Li
    Yu, Qin-Qin
    Wang, Yi
    Zeng, Su
    [J]. CHIRALITY, 2013, 25 (06) : 361 - 364
  • [38] ENHANCEMENT BY HEMIN OF THE SENSITIVITY OF K562 HUMAN-LEUKEMIC CELLS TO 1-BETA-DEUTERIUM-ARABINOFURANOSYLCYTOSINE
    OKABEKADO, J
    HAYASHI, M
    HONMA, Y
    HOZUMI, M
    [J]. CANCER RESEARCH, 1986, 46 (03) : 1239 - 1243
  • [39] Antiproliferation and apoptosis by silybin A and silybin B, two novel isomers of silybin, in human leukemic K562 cells
    Zhang, Ji-yong
    Luan, Qiu-ying
    Fu, Min
    Liu, Yan-ze
    Lee, David Y-W
    Wang, Zhao
    [J]. ACTA PHARMACOLOGICA SINICA, 2006, 27 : 323 - 324
  • [40] Ion channels in K562 cellsrelationship with the CFTR and MDR proteins
    Assef, Y
    Damiano, A
    Zotta, E
    Ibarra, C
    Kotsias, BA
    [J]. BIOPHYSICAL JOURNAL, 2002, 82 (01) : 240A - 240A